SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-053039
Filing Date
2021-11-01
Accepted
2021-11-01 07:05:22
Documents
16
Period of Report
2021-11-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-8k_20211101.htm   iXBRL 8-K 64601
2 EX-10.1 eypt-ex101_27.htm EX-10.1 111497
3 EX-99.1 eypt-ex991_6.htm EX-99.1 17673
4 GRAPHIC g3dzppm3pyvq000001.jpg GRAPHIC 17593
5 GRAPHIC gph5ej5ysemy000001.jpg GRAPHIC 5168
  Complete submission text file 0001564590-21-053039.txt   382896

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eypt-20211101.xsd EX-101.SCH 5693
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20211101_lab.xml EX-101.LAB 18582
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20211101_pre.xml EX-101.PRE 11043
9 EXTRACTED XBRL INSTANCE DOCUMENT eypt-8k_20211101_htm.xml XML 3415
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 211365285
SIC: 3826 Laboratory Analytical Instruments